ArticleJournal of the Endocrine Society2026
Disparities in utilization of high-volume thyroid surgeons for Graves disease: a statewide analysis.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Context: For patients with Graves disease undergoing surgery, the American Thyroid Association guidelines recommend referral to a high-volume thyroid surgeon (HVTS). However, factors limiting patient utilization of an HVTS are poorly understood. Objective: This study aimed to identify factors associated with utilization of an HVTS for patients with Graves. Methods: This retrospective cohort study analyzed adults with Graves who underwent thyroidectomy from January 2015 to December 2022 in a statewide claims registry. Surgeons were categorized as HV (>25 thyroidectomies/year) or low-volume (LVTS; ≤25 thyroidectomies/year). Logistic regression evaluated patient demographics, travel distance to treating HVTS hospital and closest endocrinologist, household income, area deprivation index, and education. Results: Among 764 patients treated by 130 surgeons, 17 HVTSs performed the majority (60.4%) of thyroidectomies. Most patients were female (84.3%) and White (51.0%). Patients treated by an HVTS traveled 16.8 miles farther ( Conclusion: Just more than half of patients with Graves disease received guideline-concordant surgical care by an HVTS. Enhancing patient knowledge and awareness of the benefits of HVTS care and solving transportation barriers may improve Graves patients' use of HVTS and outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.